KETANSERIN IN THE TREATMENT OF PROGRESSIVE SYSTEMIC-SCLEROSIS

被引：4
作者：
ALTOMARE, GF
PIGATTO, PD
POLENGHI, MM
机构：
来源：
ANGIOLOGY | 1988年 / 39卷 / 07期
关键词：
D O I：
10.1177/000331978803900705
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：583 / 586
页数：4
相关论文
共 15 条
[1]  
ALTOMARE GF, 1986, IN PRESS 3 ATT S INT
[2]  
CAMPBELL P M, 1975, Seminars in Arthritis and Rheumatism, V4, P351, DOI 10.1016/0049-0172(75)90017-7
[3]   MICRO-VASCULAR PATHOGENESIS OF SCLERODERMA - HYPOTHESIS [J].
FRIES, JF .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) :788-789
[4]  
HALPERN ALFRED, 1960, ANGIOLOGY, V11, P151, DOI 10.1177/000331976001100301
[5]  
HAUSTEIN UF, 1986, INT J DERMATOLO 0625, P286
[6]  
JANSSEN PAJ, 1982, ADV PHARMACOL THER, V4, P21
[7]   INCREASED FACTOR-VIII-VONWILLEBRAND FACTOR ANTIGEN AND VONWILLEBRAND-FACTOR ACTIVITY IN SCLERODERMA AND IN RAYNAUD PHENOMENON [J].
KAHALEH, MB ;
OSBORN, I ;
LEROY, EC .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (04) :482-484
[8]   ENDOTHELIAL INJURY IN SCLERODERMA [J].
KAHALEH, MB ;
SHERER, GK ;
LEROY, EC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (06) :1326-1335
[9]  
PAGANO L, 1985, IN PRESS CLIN EXPT R
[10]   TREATMENT OF RAYNAUDS-PHENOMENON WITH KETANSERIN, A SELECTIVE ANTAGONIST OF THE SEROTONIN2 (5-HT2) RECEPTOR [J].
SEIBOLD, JR ;
JAGENEAU, AHM .
ARTHRITIS AND RHEUMATISM, 1984, 27 (02) :139-146
12